Filter News
Area of Research
- (-) National Security (15)
- (-) Nuclear Science and Technology (7)
- Advanced Manufacturing (8)
- Biology and Environment (12)
- Clean Energy (48)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (7)
- Materials (36)
- Materials for Computing (6)
- Neutron Science (6)
- Quantum information Science (1)
- Supercomputing (19)
News Type
News Topics
- (-) 3-D Printing/Advanced Manufacturing (3)
- (-) Advanced Reactors (4)
- (-) Cybersecurity (10)
- (-) Grid (1)
- (-) Isotopes (2)
- (-) Machine Learning (4)
- (-) Transformational Challenge Reactor (1)
- Artificial Intelligence (6)
- Bioenergy (2)
- Biology (2)
- Biomedical (2)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (9)
- Decarbonization (1)
- Energy Storage (1)
- Environment (2)
- Exascale Computing (1)
- Frontier (1)
- Fusion (2)
- High-Performance Computing (1)
- Materials (1)
- Materials Science (2)
- National Security (11)
- Neutron Science (4)
- Nuclear Energy (11)
- Partnerships (4)
- Physics (2)
- Security (5)
- Space Exploration (2)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.